Policy Workshop: Life Sciences
Life Sciences: The Latest
  • EU Highlights
  • Viewpoints
Raiding the underwater medicine cabinet: the EU’s €9.5M venture into the sea
As resistance to traditional antibiotics reaches crisis levels, scientists are poised to forage in hard-to-reach sea trenches for new antimicrobials and novel compounds that could provide the basis of new drugs
Drug approvals show SMEs and academia are the source of most innovation
Productivity in the pharma industry is up, but the origins of more than half of new drugs lies outside corporate labs.
IMI Launches €12.2 million Flu Vaccines Call
Five year programme to develop improved tests for evaluating vaccines
Don’t let data protection kill research
Amendments to the European Data Protection regulation proposed in response to revelations of blanket electronic eavesdropping by the US must be dropped. If not, major international research projects in cancer, obesity and Alzheimer’s disease will come to a stop, say R&D funding bodies
Time to rethink the value of innovation in health
The traditional view holds that if a healthcare innovation provides any benefit - however small - it should be adopted. This approach is not sustainable, health economist Uwe Reinhardt told the European Health Forum at Bad Hofgastein, Austria
Collaboration is the critical ingredient in cell therapy
There’s a one word answer to removing bottlenecks identified in the recent House of Lords report on translating stem cell science into effective therapies, and that’s Collaboration. “It’s a no-brainer,” says leading researcher, Fiona Watt
Life Sciences Archive
Raiding the underwater medicine cabinet: the EU’s €9.5M venture into the sea
As resistance to traditional antibiotics reaches crisis levels, scientists are poised to forage in hard-to-reach sea trenches for new antimicrobials and...
Karolinska led team of researchers identifies a new general concept for the treatment of cancer
A team of researchers from five Swedish universities, led by Karolinska Institutet and the Science for Life Laboratory, have identified a...
Bioprinting new organs at Chalmers
With the new 3D Bioprinter, the research group of Professor Paul Gatenholm at the Department of Chemical and Biological Engineering exploits...
Mayor launches MedCity at Imperial College London
The Mayor of London Boris Johnson launched MedCity, a major new medical research and translation initiative, at Imperial College London today...
UCLB signs exclusive global licence with BioKier Inc. for colonic delivery of gut hormone secretagogues
UCLB has entered into an exclusive licence agreement with BioKier, Inc. for the proprietary colon delivery technology PhloralTM developed by researchers...
Page 1 of 666> 1 2 3  ... 
Innovation in Progress - Science|Business Network
Karolinska led team of researchers identifies a new general concept for the treatment of cancer
A team of researchers from five Swedish universities, led by Karolinska Institutet and the Science for Life Laboratory, have identified a new way of treating cancer. The concept is presented in the journal Nature and is based on inhibiting a specific enzyme called MTH1, which cancer cells, unlike normal cells, require for survival. Without this enzyme, oxidized nucleotides are incorporated into DNA, resulting in lethal DNA double-strand breaks in cancer cells.
Bioprinting new organs at Chalmers
With the new 3D Bioprinter, the research group of Professor Paul Gatenholm at the Department of Chemical and Biological Engineering exploits new possibilities of tissue engineering and organ regeneration.
Mayor launches MedCity at Imperial College London
The Mayor of London Boris Johnson launched MedCity, a major new medical research and translation initiative, at Imperial College London today [Tuesday 8 April].
Horizon 2020 Special Coverage
Pharma Day (Partner Event)
A high-level meeting, on the means for facilitating the transition from scientific discovery to clinical applications in oncology.
Warszaw, Poland - 25 April 2014
Research Commercialisation: From Ideas to IPO (Partner Event)
Research Commercialisation is a new cross-discipline event and will provide a platform for all those involved in promoting university-industry-investor collaboration, technology...
London, UK - 19 May 2014
ACES Selection Committee
The Academic Enterprise Awards (ACES) Selection Committee meets to short list the finalists of the 2014 awards.
Copenhagen - 23 June 2014
Unlocking the value of Personalised Healthcare in Europe
This new study shows ICT investments could cut healthcare costs for key ailments by more than 35%.
Bigger and Simpler: A short guide to the EU's €80 billion Horizon 2020 programme
A two-year political fight formally began in Brussels on 30 November with the publication of the European Commission's plan for Horizon 2020, its omnibus R&D programme. It promises less red tape, broader benefits, and more jobs and economic growth.
Biofuels: The Next Generation
Key ideas and recommendations to accelerate the deployment of sustainable biofuels have emerged at the second in a series of three high-level academic policy debates on the energy R&D challenge, The Energy Difference
Advertisement